2020
DOI: 10.1111/jcpt.13325
|View full text |Cite
|
Sign up to set email alerts
|

Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 17 publications
(22 reference statements)
0
6
0
Order By: Relevance
“…Therefore, even if one study represented each of these tools versus nine studies for MMAS‐8, this gave hope in regards to implementing them more in the clinical field. Hence, this might trigger future researchers to focus on testing them further, as they could be a safe free replacement to a previously well‐studied and frequently used scale 97 …”
Section: Discussionmentioning
confidence: 99%
“…Therefore, even if one study represented each of these tools versus nine studies for MMAS‐8, this gave hope in regards to implementing them more in the clinical field. Hence, this might trigger future researchers to focus on testing them further, as they could be a safe free replacement to a previously well‐studied and frequently used scale 97 …”
Section: Discussionmentioning
confidence: 99%
“…The higher the score, the better the medication compliance. Complete compliance: 8 points; partial compliance: 6–7 points; and non-compliance: <6 points ( 14 ). Total compliance rate = cases of (complete compliance + partial compliance)/total number of cases × 100%.…”
Section: Methodsmentioning
confidence: 99%
“…<6 points (14). Total compliance rate = cases of (complete compliance + partial compliance)/total number of cases × 100%.…”
Section: Medication Compliancementioning
confidence: 99%
“…The term FIASMA (Functional Inhibitor of Acid SphingoMyelinAse) encompasses a family of drugs, many of them approved for use in humans, which have been shown to indirectly inhibit the activity of aSMase [ 100 ]. Interestingly, recent studies have shown that inhibition of lysosomal SMase via these inhibitors prevents infection of the SARS-CoV-2 virus [ 101 , 102 , 103 ]. In Niemann–Pick disease, it has been observed that aSMase dysfunction leads to a dysregulation of lysosomes, causing a disruption of cholesterol transport [ 104 ].…”
Section: Enzymes Of Ceramide Metabolismmentioning
confidence: 99%